Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest

[1]  G L Snyder,et al.  Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? , 2001, The Journal of biological chemistry.

[2]  L. Meijer,et al.  Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells , 2001, British Journal of Cancer.

[3]  F. Tamanoi,et al.  Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines , 2000, Oncogene.

[4]  Laurent Meijer,et al.  Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[5]  Doris Marko,et al.  Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases , 1999, Nature Cell Biology.

[6]  F. Lallemand,et al.  Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication. , 1999, Experimental cell research.

[7]  L. Meijer,et al.  Inhibiteurs chimiques des kinases dépendantes des cyclines : recherche et applications thérapeutiques potentielles , 1999 .

[8]  M. Shimizu,et al.  Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole. , 1999, Anti-cancer drugs.

[9]  K. Vousden,et al.  Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression , 1998, Oncogene.

[10]  L. Hengst,et al.  Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication , 1998, Molecular and Cellular Biology.

[11]  S. Kaufmann,et al.  Antineoplastic Agents: the Importance of Sequence of Administration' , 2022 .

[12]  C. Gilbert,et al.  Construction by gene targeting in human cells of a ‘conditional’ CDC2 mutant that rereplicates its DNA , 1997, Nature Genetics.

[13]  L. Meijer,et al.  Chemical inhibitors of cyclin-dependent kinases , 1997 .

[14]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[15]  Laurent Meijer,et al.  Sequential Dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the Prophase/Metaphase Transition* , 1996, The Journal of Biological Chemistry.

[16]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Bradbury,et al.  A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. , 1996, Cancer research.

[18]  Y. Kai,et al.  THE SYNTHESIS, ANTILEUKEMIC ACTIVITY, AND CRYSTAL STRUCTURES OF INDIRUBIN DERIVATIVES , 1996 .

[19]  M. Madine,et al.  Mechanisms restricting DNA replication to once per cell cycle: MCMS, pre-replicative complexes and kinases. , 1996, Trends in cell biology.

[20]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[21]  Rui Han,et al.  Highlight on the studies of anticancer drugs derived from plants in china , 1994, Stem cells.

[22]  Professor Dr. Weici Tang,et al.  Chinese Drugs of Plant Origin , 1992, Springer Berlin Heidelberg.

[23]  Gerhard Eisenbrand,et al.  Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine , 1992 .

[24]  M. Yoshida,et al.  Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a , 1991, The Journal of cell biology.

[25]  L. Meijer,et al.  Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions. , 1988, Experimental cell research.

[26]  Richard Cole,et al.  A Parallel Median Algorithm , 1985, Inf. Process. Lett..

[27]  Ji Xj,et al.  [Studies on antineoplastic action of indirubin derivatives and analogs and their structure-activity relationships]. , 1985 .

[28]  G. Kimura,et al.  Formation of proliferative tetraploid cells after treatment of diploid cells with sodium butyrate in rat 3Y1 fibroblasts , 1985, Journal of cellular physiology.

[29]  Hson-Mou Chang.  Advances in Chinese medicinal materials research , 1985 .

[30]  Wang Yao.  The Formation of the Lama Religion in Tibet , 1983 .

[31]  Ji Xj,et al.  [Studies on the antineoplastic action and toxicity of synthetic indirubin (author's transl)]. , 1981 .

[32]  I. V. Uryvaeva,et al.  Cell polyploidy: its relation to tissue growth and function. , 1977, International review of cytology.

[33]  M. De Brabander,et al.  Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. , 1976, Biochemical and biophysical research communications.